Literature DB >> 20333708

Use of mechanical assist during high-risk PCI and STEMI with cardiogenic shock.

Tillmann Cyrus1, Santhosh J Mathews, John M Lasala.   

Abstract

Infarct size may be reduced by left ventricular unloading after ST-segment elevation MI (STEMI) in addition to reperfusion therapy. Likewise, high-risk percutaneous coronary intervention (PCI) may benefit from periprocedural support especially in patients with low cardiac output at baseline or when periprocedural hemodynamic deterioration is anticipated. Traditionally, intraaortic balloon-pumps have been used in acute MI with cardiogenic shock. As this modality has limited hemodynamic benefits, new developments have focused on active hemodynamic assist devices. These devices actively unload the left ventricle increasing cardiac output by 2.5-5 L/min and are increasingly easier to implant and monitor. Thus, interventional cardiologists will be able to offer a safer more effective alternative to an increasing patient population with complex cardiac conditions and high-risk PCI. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20333708     DOI: 10.1002/ccd.22366

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Short-term mechanical management of cardiogenic shock.

Authors:  Jessica L Brown; Roberta C Bogaev; Jack O'Connell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-08

2.  Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline.

Authors:  Karl Werdan; Martin Ruß; Michael Buerke; Georg Delle-Karth; Alexander Geppert; Friedrich A Schöndube
Journal:  Dtsch Arztebl Int       Date:  2012-05-11       Impact factor: 5.594

3.  Trends, etiologies, and predictors of 90-day readmission after percutaneous ventricular assist device implantation: A national population-based cohort study.

Authors:  Hafeez Ul Hassan Virk; Byomesh Tripathi; Shuchita Gupta; Akanksha Agrawal; Sandeep Dayanand; Faisal Inayat; Chayakrit Krittanawong; Ali Raza Ghani; Mohammad Nour Zabad; Parasuram Melarcode Krishnamoorthy; Aman Amanullah; Gregg Pressman; Christian Witzke; Sean Janzer; Jon George; Sanjog Kalra; Vincent Figueredo
Journal:  Clin Cardiol       Date:  2018-05-10       Impact factor: 2.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.